Changgui Li

发表

Safety and immunogenicity of an inactivated adjuvanted whole-virion influenza A (H5N1) vaccine: a phase I randomised controlled trial

Yu Wang, Qiang Gao, Zijian Feng, 2006, The Lancet.

Protection against Multiple Subtypes of Influenza Viruses by Virus-Like Particle Vaccines Based on a Hemagglutinin Conserved Epitope

Fang Fang, Wenting Xu, Ze Chen, 2015, BioMed research international.

Antigenic stability of H1N1 pandemic vaccines correlates with vaccine strain.

Xuguang Li, A. Farnsworth, T. Cyr, 2011, Vaccine.

Tandem repeats of Sushi3 peptide with enhanced LPS-binding and -neutralizing activities.

Jeak Ling Ding, J. L. Ding, Bow Ho, 2003, Protein engineering.